Granulocyte contamination is usually discovered rather than anticipated. A phenotyping panel shows a population nobody expected, a functional assay produces a background that will not go away, or a preparation clumps during handling. The cause is rarely a mistake at the bench. It is generally a property the material arrived with, established before anyone in your lab touched it.
Why they are there at all
Granulocytes are the most abundant white cell in circulation, so any leukocyte collection starts with a great many of them. Density gradient separation removes most, because granulocytes are denser than mononuclear cells and pellet below the interface where PBMCs band.
That separation depends on granulocytes actually being denser, which is true of fresh, resting granulocytes and progressively less true as time passes.
What changes with time
Granulocytes are short-lived and highly reactive. Removed from circulation and held in a bag, they begin to activate and to die, and both processes change their density. Activated and apoptotic granulocytes become less dense, and a growing proportion of them stop pelleting cleanly and start banding with the mononuclear layer instead.
So delay does not merely reduce PBMC purity in a linear way. It converts a population that separation was designed to remove into a population that separation can no longer distinguish. This is why the interval between collection and first processing is the single most consequential variable in granulocyte carryover, and why it is almost entirely determined before the material reaches you.
Related product
Leukopak formats. Whole, half, quarter and custom single-donor units, fresh or cryopreserved.
What contamination does to your data
| Assay | Effect |
|---|---|
| Flow cytometry | Extra events, autofluorescence, non-specific antibody binding, distorted frequencies |
| Functional and cytokine assays | Released proteases and reactive oxygen species alter the readout and can degrade cytokines |
| Cytotoxicity assays | Background killing not attributable to the effector population you are studying |
| Cell culture | Dying granulocytes release DNA that clumps the preparation and traps viable cells |
| Downstream isolation | Reduced purity and yield of the target population |
The clumping deserves emphasis because it compounds. DNA released from dying cells forms strands that physically capture healthy cells, so a contaminated preparation loses viable cells in proportion to how contaminated it is.
What you can still do at the bench
Process on receipt rather than at a convenient time. Keep the gradient at the temperature your protocol specifies, since density separation is temperature sensitive. Do not use the centrifuge brake. Consider a DNase step if clumping is visible, which addresses the released DNA rather than the granulocytes themselves. And measure what you actually have rather than assuming the isolation worked, because an unmeasured contamination is one you will attribute to something else later.
What only the supplier can do
Collection quality sets the starting granulocyte fraction, and the interval before first processing determines how much of it becomes inseparable. Neither is available to the buyer as a lever. The structural response is to place collection and processing in the same operation rather than moving material between them, which is how OrganaBio runs it, collecting through its own apheresis subsidiary and processing within the same operation across Miami, Irvine, Hayward and San Diego.
Where a program would rather avoid the isolation step entirely, cryopreserved PBMCs and isolated T and NK populations come from the same donor program as the leukopaks. Yield mechanics are covered in PBMC yield from a leukopak.
Frequently asked questions
Why do granulocytes end up in a PBMC preparation?
Density gradient separation removes granulocytes because they are denser than mononuclear cells and pellet below the interface. That holds for fresh, resting granulocytes. As they activate and die their density falls, and a growing proportion band with the mononuclear layer instead.
Does granulocyte contamination increase with time from collection?
Yes, and progressively. Granulocytes are short-lived and reactive, and once removed from circulation they begin activating and dying. Both processes reduce their density, converting a population that separation was designed to remove into one it can no longer distinguish.
How does granulocyte contamination affect flow cytometry?
It adds events, contributes autofluorescence and non-specific antibody binding, and distorts the frequencies of the populations you are measuring. Contamination that is not quantified tends to get attributed to something else later.
Why do contaminated PBMC preparations clump?
Dying granulocytes release DNA that forms strands and physically traps viable cells. The effect compounds, so a contaminated preparation loses healthy cells in proportion to how contaminated it is. A DNase step addresses the released DNA rather than the granulocytes themselves.
What can I do at the bench to reduce carryover?
Process on receipt rather than at a convenient time, hold the gradient at the specified temperature since separation is temperature sensitive, avoid the centrifuge brake, consider DNase if clumping is visible, and measure the contamination rather than assuming the isolation worked.
Is granulocyte contamination a supplier problem or a lab problem?
Largely a supplier property. Collection quality sets the starting fraction and the interval before first processing determines how much becomes inseparable, and neither is available to the buyer as a lever once the material has shipped.
What should I ask a supplier about granulocyte carryover?
Ask what the interval is between collection and first processing, and treat a shipping-time answer as a non-answer. The structural solution is co-located collection and processing rather than improved packaging.
Talk to OrganaBio
Need this material for a specific process?
Formats, vial sizes and donor characterization vary by product, and custom formats are documented where a process needs them. Tell us what your process requires and the scientific team will confirm what can be supplied.
